Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 31.12.2025 MISL.LN IE000NVDQXE1 3,025,002.00 USD 97,083,666.86 32.094  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 31.12.2025 QSEP.LN IE000FQ808R5 450,002.00 USD 10,293,242.17 22.874  ...
-

Immunotherapy Drugs Global Markets Report 2025: Historical Revenue Data for 2022-2024, Estimate Figures for 2025, and Forecasts for 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Immunotherapy Drugs: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030. Despite challenges, the immunotherapy field is rapidly evolving, with researchers developing more effective approaches such as perso...
-

Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic Collaborations - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Biological Therapies for Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030. The biological therapies for cancer market has experienced rapid growth, driven by increasing ad...
-

AMC Theatres Declares Netflix’s Stranger Things Series Finale Theatrical Event a Triumph; More Joint Netflix-AMC Cooperation Envisioned in 2026 and Beyond

LEAWOOD, Kan.--(BUSINESS WIRE)--Adam Aron, Chairman and CEO of AMC Entertainment (NYSE: AMC), the world's largest theatrical exhibitor, issued the following statement today: “A few months ago, we announced that in September of 2025, a high-level dialogue between AMC and Netflix led to both companies pledging to explore ways to visibly begin working together. This led quickly to AMC showing, in many of its theatres, a Halloween bring-back of Netflix's immensely popular KPop Demon Hunters. It was...
-

Tesla Fourth Quarter 2025 Production, Deliveries & Deployments

AUSTIN, Texas--(BUSINESS WIRE)--In the fourth quarter, we produced over 434,000 vehicles, delivered over 418,000 vehicles and deployed 14.2 GWh of energy storage products – a record for deployments. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q4 2025   Production Deliveries Subject to operating lease accounting Model 3/Y 422,652 406,585 3% Other Models 11,706 11,642 5% Total 434,358 418,227 3% 2025   Production Delive...
-

Calix to Post Fourth Quarter 2025 Results on January 28, 2026

SAN JOSE, Calif.--(BUSINESS WIRE)--Calix, Inc. (NYSE:CALX) today announced that on Wednesday, January 28, 2026, after market close, the company will post on the Calix Investor Relations website its fourth quarter 2025 stockholder letter for the period ended December 31, 2025. The posting of the stockholder letter will be announced over the newswire with a link to the letter to stockholders available at https://investor-relations.calix.com/. Calix will host a conference call to discuss these res...
-

FHLBank Chicago Expands Community Advance for 2026 to Accelerate Affordable Housing and Economic Development

CHICAGO--(BUSINESS WIRE)--The Federal Home Loan Bank of Chicago (FHLBank Chicago) today announced the opening of its Community Advance product for 2026, reaffirming its commitment to affordable housing and local development. Backed by $55 million in annual interest rate subsidy, the program helps member institutions fund housing, support small businesses, and expand access to capital in communities that need it most. Interest rate discounts of up to 200 basis points (bps), a $200,000 per-member...
-

Atropos Health Appoints Kevin Smith to Chief Growth Officer to Accelerate Expansion of AI-Driven Real-World Evidence

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), today announced the appointment of Kevin Smith to Chief Growth Officer, effective immediately. Previously serving as a key leader within the company’s commercial organization, Smith will now oversee new business development for both health system and life science organizations and the expansion of the adoption of agentic solutions for clinical deci...
-

Principal Financial Group to Hold Combined Earnings and Outlook Call

DES MOINES, Iowa--(BUSINESS WIRE)--Principal Financial Group® (Nasdaq: PFG) announced today that it will release fourth quarter and full year 2025 financial results and the company’s outlook for 2026 after U.S. markets close on Monday, February 9, 2026. On Tuesday, February 10, 2026, at 10 a.m. ET, Deanna Strable, chair, president, and chief executive officer, and Joel Pitz, executive vice president and chief financial officer, will discuss the results during a live conference call. Other membe...